These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23246245)

  • 41. Gender moderates the impact of stereotype threat on cognitive function in cannabis users.
    Looby A; Earleywine M
    Addict Behav; 2010 Sep; 35(9):834-9. PubMed ID: 20483199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subjective effects of cannabis before the first psychotic episode.
    Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities.
    Clough AR; D'Abbs P; Cairney S; Gray D; Maruff P; Parker R; O'Reilly B
    Drug Alcohol Rev; 2004 Dec; 23(4):381-90. PubMed ID: 15763742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurocognitive consequences of marihuana--a comparison with pre-drug performance.
    Fried PA; Watkinson B; Gray R
    Neurotoxicol Teratol; 2005; 27(2):231-9. PubMed ID: 15734274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers?
    Schaub M; Fanghaenel K; Senn C; Stohler R
    Subst Use Misuse; 2008 Dec; 43(14):2045-52. PubMed ID: 19085437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B
    Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The interactive effects of emotional clarity and cognitive reappraisal on problematic cannabis use among medical cannabis users.
    Boden MT; Gross JJ; Babson KA; Bonn-Miller MO
    Addict Behav; 2013 Mar; 38(3):1663-8. PubMed ID: 23254215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathways to psychosis in cannabis abuse.
    Shrivastava A; Johnston M; Terpstra K; Bureau Y
    Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):30-5. PubMed ID: 23491968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perceptions of the cognitive effects of cannabis use: A survey of neuropsychologists' beliefs.
    Hirst RB; Watson J; S Rosen A; Quittner Z
    J Clin Exp Neuropsychol; 2019 Mar; 41(2):133-146. PubMed ID: 30124369
    [No Abstract]   [Full Text] [Related]  

  • 53. [Can cannabis use increase the risk for schizophrenic psychoses?].
    Bugra H; Rapp C; Studerus E; Aston J; Borgwardt S; Riecher-Rössler A
    Fortschr Neurol Psychiatr; 2012 Nov; 80(11):635-43. PubMed ID: 23139065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurocognitive moderation of associations between cannabis use and psychoneuroticism.
    Huijbregts SC; Griffith-Lendering MF; Vollebergh WA; Swaab H
    J Clin Exp Neuropsychol; 2014; 36(8):794-805. PubMed ID: 25116129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
    Hall W
    Addiction; 2015 Jan; 110(1):19-35. PubMed ID: 25287883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.
    Broyd SJ; van Hell HH; Beale C; Yücel M; Solowij N
    Biol Psychiatry; 2016 Apr; 79(7):557-67. PubMed ID: 26858214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Review: executive functioning and cannabis use].
    Almeida PP; Novaes MA; Bressan RA; Lacerda AL
    Braz J Psychiatry; 2008 Mar; 30(1):69-76. PubMed ID: 18373021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder.
    Hájková M; Knížková K; Siroňová A; Keřková B; Jonáš J; Šustová P; Dorazilová A; Rodriguez M
    Cogn Neuropsychiatry; 2021 Jul; 26(4):257-272. PubMed ID: 33973827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive functioning of adolescent and young adult cannabis users in the Philadelphia Neurodevelopmental Cohort.
    Scott JC; Wolf DH; Calkins ME; Bach EC; Weidner J; Ruparel K; Moore TM; Jones JD; Jackson CT; Gur RE; Gur RC
    Psychol Addict Behav; 2017 Jun; 31(4):423-434. PubMed ID: 28414475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.